Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 313,087
  • Shares Outstanding, K 25,579
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,630 K
  • 60-Month Beta 1.47
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.99
Trade SAVA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.70 +82.39%
on 12/29/20
13.68 -10.67%
on 01/19/21
+4.39 (+56.07%)
since 12/21/20
3-Month
6.70 +82.39%
on 12/29/20
13.68 -10.67%
on 01/19/21
+3.31 (+37.15%)
since 10/21/20
52-Week
1.63 +649.69%
on 05/15/20
13.68 -10.67%
on 01/19/21
+4.33 (+54.88%)
since 01/21/20

Most Recent Stories

More News
Tech Stocks Lead Market Higher to Begin Short Week

Tech Stocks Lead Market Higher to Begin Short Week

CSX : 91.68 (-1.64%)
AIMC : 57.10 (+2.38%)
VET : 5.69 (-3.23%)
FLDM : 6.21 (+5.97%)
BJ : 42.47 (+1.94%)
STMP : 225.38 (+2.54%)
BYND : 133.57 (-1.21%)
IIPR : 196.70 (+0.55%)
RUN : 87.53 (+6.87%)
NEO : 55.99 (-0.36%)
ETSY : 213.36 (-1.08%)
GDRX : 42.63 (+1.74%)
XOM : 48.19 (-2.71%)
JBL : 45.66 (+0.33%)
OLN : 26.19 (-0.91%)
HUN : 28.16 (+0.04%)
OMI : 25.99 (-4.34%)
CLF : 16.34 (-4.22%)
MAT : 18.27 (-0.33%)
NAVI : 11.30 (-1.82%)
TGNA : 15.78 (+3.68%)
AES : 27.33 (-2.46%)
BABA : 260.05 (-2.05%)
FB : 272.54 (+1.89%)
GOOG : 1,897.32 (+0.55%)
NFLX : 580.24 (-1.04%)
GS : 290.05 (-0.14%)
BAC : 31.93 (-1.27%)
JPM : 135.31 (-0.49%)
C : 62.02 (-1.94%)
WFC : 32.14 (-0.99%)
SAVA : 12.08 (-1.31%)
BB : 12.87 (+0.63%)
INSG : 18.77 (+4.57%)
S&P, NASDAQ Move Higher for Second Straight Session

S&P, NASDAQ Move Higher for Second Straight Session

RNST : 37.38 (-1.24%)
SJR : 17.78 (+0.51%)
ECHO : 28.11 (+0.90%)
AHCO : 38.13 (+0.61%)
LAC : 22.92 (+3.10%)
INFN : 9.67 (+0.83%)
SHOP : 1,203.85 (+0.24%)
MAR : 127.00 (+0.21%)
YNDX : 68.71 (-2.33%)
NEO : 55.99 (-0.36%)
RUN : 87.53 (+6.87%)
SAVA : 12.08 (-1.31%)
NFLX : 580.24 (-1.04%)
AAPL : 136.93 (+3.71%)
AMZN : 3,314.50 (+1.57%)
First Positive Session of 2021

First Positive Session of 2021

STZ : 228.23 (+0.32%)
ROAD : 32.66 (-2.71%)
TTC : 100.61 (+0.19%)
SAVA : 12.08 (-1.31%)
ORBC : 9.07 (+2.95%)
DBD : 13.08 (+16.99%)
LVS : 55.24 (+1.49%)
V : 205.84 (-0.08%)
COP : 43.14 (-4.89%)
INTU : 384.91 (-1.17%)
BMRN : 86.62 (-1.56%)
MAR : 127.00 (+0.21%)
PDD : 173.36 (+1.40%)
LUV : 47.69 (-1.08%)
Cassava Sciences' (SAVA) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Cassava Sciences (SAVA).

SAVA : 12.08 (-1.31%)
The Biotech Breakthrough Transforming Mental Health

, /PRNewswire/ -- Thanks in large part to the global COVID-19 pandemic, 2020 has been a year of tremendous challenges and adversity. But those historic challenges have also been met with impressive resiliency...

SAGE : 92.76 (+1.70%)
SAVA : 12.08 (-1.31%)
CMPS : 44.70 (-0.27%)
STIM : 18.43 (+11.09%)
ACHC : 51.60 (-0.98%)
Pacira (PCRX) Gets European Commission Approval for Exparel

The EC approves Pacira's (PCRX) Exparel for treating post-operative pain in adults and as a field block for treating somatic post-operative pain from small- to medium-sized surgical wounds in adults.

BLRX : 2.53 (+3.27%)
PCRX : 69.65 (-5.03%)
CTLT : 118.67 (-0.84%)
SAVA : 12.08 (-1.31%)
OptiNose (OPTN) Looks Good: Stock Adds 6.2% in Session

OptiNose (OPTN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

SAVA : 12.08 (-1.31%)
Aerie (AERI) Gets Positive CHMP Opinion for Roclanda in EU

Aerie (AERI) receives positive CHMP opinion for Roclanda for reduction of elevated intraocular pressure in adult patients.

BLRX : 2.53 (+3.27%)
AERI : 16.57 (+3.82%)
CTLT : 118.67 (-0.84%)
SAVA : 12.08 (-1.31%)
Zoetis (ZTS) Librela Gets Marketing Authorization in Europe

Zoetis (ZTS) gets marketing authorization for Librela, for monthly alleviation of osteoarthritis pain in dogs.

ZTS : 164.74 (+0.84%)
BLRX : 2.53 (+3.27%)
CTLT : 118.67 (-0.84%)
SAVA : 12.08 (-1.31%)
Jazz Pharma (JAZZ) Beats on Q3 Earnings, Ups Sales Guidance

Jazz Pharmaceuticals (JAZZ) reports better-than-expected third-quarter 2020 earnings and revenues and ups its sales guidance for 2020.

ENDP : 6.86 (-2.42%)
JAZZ : 165.94 (-0.81%)
USNA : 85.37 (+0.61%)
SAVA : 12.08 (-1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 14.62
2nd Resistance Point 13.95
1st Resistance Point 13.10
Last Price 12.08
1st Support Level 11.58
2nd Support Level 10.91
3rd Support Level 10.06

See More

52-Week High 13.68
Last Price 12.08
Fibonacci 61.8% 9.08
Fibonacci 50% 7.66
Fibonacci 38.2% 6.23
52-Week Low 1.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar